Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

DSGN stock hub

Design Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

DSGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

888.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

DSGN

In the news

Latest news · DSGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-31.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-21.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All DSGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001807120
Company name	Design Therapeutics, Inc.
Country	United States
Country code	US
Cusip	25056L103
Employees	54
Employees Change	0%
Employees Change Percent	0
Enterprise value	$668M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-03-26
Isin	US25056L1035
Last refreshed	2026-05-10
Market cap	$888.1M
Market cap category	Small-Cap
Price	$14.22
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	DSGN
Website	https://www.designtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.85%
FCF yield	-6.09%
P/B ratio	4.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-58.1M
Net Income	$-69.7M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-1.3M
ROA	-20.93
Roa5y	-14.52
ROCE	-35.58
ROE	-31.26
Roe5y	-21.36
ROIC	-21.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	327.45%
Cagr3y	23.33%
Cagr5y	-12.71%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$230.4M
Cash	$222.8M
Current Assets	$227M
Current Liabilities	$10.2M
Debt	$2.7M
Debt Equity	$0.01
Equity	$218.1M
Liabilities	$12.4M
Long Term Assets	$3.4M
Long Term Liabilities	$2.2M
Net Cash	$220.1M
Net Cash By Market Cap	$24.78
Net Cash Growth	-3.27%
Net Debt Equity	$-1.01
Tangible Book Value	$218.1M
Tangible Book Value Per Share	$3.49
WACC	13.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	22.28
Net Working Capital	$-5.4M
Quick ratio	22.05
Working Capital	$216.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.26%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	327.03%
200-day SMA	8.63
3Y total return	87.6%
50-day SMA	11.77
50-day SMA vs 200-day SMA	50over200
5Y total return	-49.3%
All Time High	50.5
All Time High Change	-71.84%
All Time High Date	2021-03-26
All Time Low	1.94
All Time Low Change	632.99%
All Time Low Date	2023-08-22
ATR	0.99
Beta	1.74
Beta1y	0.28
Beta2y	1.12
Ch YTD	51.6
High	14.6
High52	17.25
High52 Date	2026-04-29
High52ch	-17.57%
Low	13.97
Low52	3.11
Low52 Date	2025-05-15
Low52ch	357.97%
Ma50ch	20.8%
Price vs 200-day SMA	64.72%
RSI	59.34
RSI Monthly	71.32
RSI Weekly	79.71
Sharpe ratio	2.2x
Sortino ratio	3.88
Total Return	-3.26%
Tr YTD	51.6
Tr1m	16.37%
Tr1w	6.92%
Tr3m	38.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	3
Analyst Price Target Top	$15.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.34
Operating Income	$-78.4M
Price target	$16.4
Price Target Change	$15.33
Price Target Change Top	$10.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29,988,072%
Float Percent	48.01%
Shares Insiders	14.26%
Shares Institutions	42.24%
Shares Out	62,456,974
Shares Qo Q	4.6%
Shares Yo Y	3.26%
Short Float	7.46%
Short Ratio	6.68
Short Shares	3.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-69.1M
Average Volume	556,408.25x
Bv Per Share	3.49
CAPEX	$-121,000
Ch1m	16.37
Ch1w	6.92
Ch1y	327
Ch3m	38.46
Ch3y	87.6
Ch5y	-49.3
Ch6m	88.1
Change	0.85%
Change From Open	1.43
Close	14.1
Days Gap	-0.57
Depreciation Amortization	620,000
Dollar Volume	5,730,418.3
Earnings Date	2026-04-28
Earnings Time	amc
EBIT	$-78.4M
EBITDA	$-77.7M
EPS	$-1.19
F Score	1
FCF	$-54.1M
FCF EV Yield	-8.1x
FCF Per Share	$-0.87
Financing CF	45,649,000
Fiscal Year End	December
Founded	2,017
Investing CF	7,454,000
Ipr	-28.9
Iprfo	-49.21
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-09
Ma150	9.71
Ma150ch	46.49%
Ma20	13.31
Ma20ch	6.81%
Net CF	-897,000
Next Earnings Date	2026-08-06
Open	14.02
Optionable	Yes
Position In Range	39.68
Post Close	14.22
Postmarket Change Percent	1.97
Postmarket Price	$14.5
Ppne	3,393,000
Price Date	2026-05-08
Ptbv Ratio	4.07
Relative Volume	0.72x
Share Based Comp	14,934,000
Tr6m	88.1%
Us State	California
Volume	402,983

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does DSGN pay a dividend?

Capital-return profile for this ticker.

Performance

DSGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns DSGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+42.2%

Float: +48.0% of shares outstanding

Insider ownership

+14.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

DSGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.3

Neutral momentum band

Price vs 200-day MA

+64.7%

50/200-day relationship not available

Beta (5Y)

1.74

More volatile than the market

Sharpe ratio

2.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About DSGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current DSGN stock rating?

Design Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full DSGN analysis?

The full report lives at /stocks/DSGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for DSGN?

The latest report frames DSGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the DSGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.